Capital increase placed successfully

  ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is solely
  responsible for the content of this announcement.


Curanum AG, which is listed in the Prime Standard, has placed 6,532,000 new shares among shareholders on the basis of the subscription offer that was published in the electronic Federal Gazette on April 11, 2011. Interest in the new shares significantly exceeded the offering volume due to shareholders' oversubscription requests. For this reason, not all shareholders' oversubscription requests could be fully considered. Shareholders' oversubscription requests received allocations in proportion to their subscription right entitlements in line with the principle of equal treatment. Information about the oversubscription will be published on Curanum's website at Relations/Capital Increase on May 4, 2011.

Curanum AG's share capital is raised from currently EUR 32,660,000.00 to EUR 39,192,000.00 as a result of the capital increase. The capital increase will generate gross issue proceeds of around EUR 11,757,600 less placement costs for Curanum AG. The company will deploy the cash inflow to continue on its growth path.

The new shares are to be admitted to trading prospectively in the 20th calendar week following the shortly forthcoming entry of the capital increase in the commercial register, and the new shares will be delivered subsequently.

end of announcement                               euro adhoc


Caroline Lutz
Tel.: + 49 89 242065 17

Branche: Healthcare Providers
ISIN: DE0005240709
WKN: 524070
Index: CDAX, Classic All Share, Prime All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
München / regulated dealing

Weitere Meldungen: CURANUM AG

Das könnte Sie auch interessieren: